Domestic Pharmaceutical Distributor / Prime Contractor Partner

The contract requires a domestic distributor or prime partner to source, certify, and deliver Erythromycin Ointment under terms established by the Defense Logistics Agency, ensuring all materials and processes originate fully within the United States with verified domestic content. The entity must comply with all regulatory and contractual obligations to guarantee product quality, certification, and timely delivery to the designated place of performance at Fort Bragg, North Carolina. This subcontract is part of the Medical Supply Chain Pharmaceutical FSA’s mission within the Department of Defense to maintain a reliable, domestically sourced pharmaceutical supply chain. The solicitation, posted on July 12, 2026, with a response deadline of July 20, 2026, is classified under NAICS code 424210 for pharmaceutical and bulk drug merchant wholesalers. Participation requires full adherence to DLA contracting standards, including certification of domestic origin for all components and manufacturing steps. The contract is structured as a subcontract, indicating the successful bidder will operate under the broader supply agreement with the Department of Defense, ensuring uninterrupted availability of this critical medication to military medical facilities. All activities must be conducted in strict compliance with federal procurement regulations and pharmaceutical quality controls.